N. patients (%) | Non-STR (n = 457) | STR (n = 96) | P value | |
---|---|---|---|---|
Baseline calendar year | ||||
1999–2003 | 187 (33.8) | 187 (40.9) | / | |
2004–2007 | 181 (32.7) | 181 (39.6) | / | |
2008-2012 | 185 (33.5) | 89 (48.1) | 96 (100.0) | |
Age, years a | 39 (33–45) | 38 (33–45) | 42 (32–47) | 0.06 |
Male gender | 391 (70.7) | 324 (70.9) | 67 (69.8) | 0.83 |
Non-Italian nationality | 130 (23.0) | 103 (23.4) | 27 (28.1) | 0.24 |
Injecting drug use (as risk factor) | 93 (11.4) | 57 (12.5) | 6 (6.3) | 0.08 |
CDC class C | 130 (23.5) | 109 (23.9) | 21 (21.9) | 0.68 |
Years from HIV diagnosis a | 2.6 (0.7-7.4) | 2.5 (0.5-7.4) | 3.0 (1.4-7.6) | 0.09 |
Naïve | 283 (51.2) | 248 (54.3) | 35 (36.5) | 0.002 |
Number of treatment lines at EFV start a,c | 2 (2–3) | 3 (2–3) | 2 (2–3) | 0.17 |
Baseline Viral Load, log copies/mL a,b | 4.8 (4.6-5.2) | 4.8 (4.6-5.3) | 4.8 (4.1-5.3) | 0.35 |
Nadir CD4 cells count, cells/μL a | 196 (93–262) | 180 (91–248) | 246 (121–326) | 0.1 |
Baseline CD4 cells count, cells/μL a | 300 (207–437) | 275 (185–433) | 430 (322–573) | 0.55 |
Co-administered NRTIs: | ||||
TDF + FTC/3TC | 315 (57.0) | 219 (47.9) | 96 (100.0) | |
ABC + 3TC | 21 (3.8) | 21 (4.6) | / | |
AZT + 3TC | 130 (23.5) | 130 (28.5) | / | |
Other | 87 (15.7) | 87 (19.0) | / |